NO20003220L - Farmasøytiske preparater omfattende miceller innbefattende lipofilt glukokortikosteroid og kun ett overflateaktivt middel - Google Patents

Farmasøytiske preparater omfattende miceller innbefattende lipofilt glukokortikosteroid og kun ett overflateaktivt middel

Info

Publication number
NO20003220L
NO20003220L NO20003220A NO20003220A NO20003220L NO 20003220 L NO20003220 L NO 20003220L NO 20003220 A NO20003220 A NO 20003220A NO 20003220 A NO20003220 A NO 20003220A NO 20003220 L NO20003220 L NO 20003220L
Authority
NO
Norway
Prior art keywords
surfactant
pharmaceutical preparations
including lipophilic
micelles including
lipophilic glucocorticosteroid
Prior art date
Application number
NO20003220A
Other languages
English (en)
Other versions
NO20003220D0 (no
Inventor
Gabrielle Sjoequist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20003220D0 publication Critical patent/NO20003220D0/no
Publication of NO20003220L publication Critical patent/NO20003220L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20003220A 1997-12-22 2000-06-21 Farmasøytiske preparater omfattende miceller innbefattende lipofilt glukokortikosteroid og kun ett overflateaktivt middel NO20003220L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (sv) 1997-12-22 1997-12-22 New formulation
PCT/SE1998/002426 WO1999032089A1 (en) 1997-12-22 1998-12-22 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant

Publications (2)

Publication Number Publication Date
NO20003220D0 NO20003220D0 (no) 2000-06-21
NO20003220L true NO20003220L (no) 2000-08-22

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003220A NO20003220L (no) 1997-12-22 2000-06-21 Farmasøytiske preparater omfattende miceller innbefattende lipofilt glukokortikosteroid og kun ett overflateaktivt middel

Country Status (20)

Country Link
EP (1) EP1043973A1 (no)
JP (1) JP2001526210A (no)
KR (1) KR20010024789A (no)
CN (1) CN1283106A (no)
AR (1) AR017220A1 (no)
AU (1) AU1993599A (no)
BR (1) BR9813811A (no)
CA (1) CA2315782A1 (no)
EE (1) EE200000388A (no)
HU (1) HUP0102365A3 (no)
ID (1) ID26945A (no)
IL (1) IL136880A0 (no)
NO (1) NO20003220L (no)
NZ (1) NZ505073A (no)
PL (1) PL341361A1 (no)
SE (1) SE9704833D0 (no)
SK (1) SK9532000A3 (no)
TR (1) TR200001977T2 (no)
WO (1) WO1999032089A1 (no)
ZA (1) ZA9811461B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (sv) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
PT1305329E (pt) 2000-08-05 2007-12-24 Glaxo Group Ltd Éster s-fluorometílico do ácido 6.alfa.,9.alfa.-difluoro- 17.alfa.-(2-furanilcarboxil)oxi-11.beta.-hidroxi-16.alfa.-metil- 3-oxo-androsta-1,4-dieno-17-carbotióico como um agente antiinflamatório
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
SE0100901D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
MY137522A (en) 2001-04-30 2009-02-27 Glaxo Group Ltd Novel anti-inflammatory androstane derivatives.
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JPWO2005018607A1 (ja) * 2003-08-20 2007-11-01 味の素株式会社 溶解性を改善した医薬品製剤
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
US20090131386A1 (en) 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
DK3354276T3 (da) * 2007-11-13 2020-03-30 Meritage Pharma Inc Sammensætninger til behandlingen af gastrointestinal inflammation
KR20110056516A (ko) * 2008-09-12 2011-05-30 크리티컬 파머수티컬스 리미티드 점막 또는 피부를 통한 치료제의 흡수 개선
CN101982168B (zh) * 2010-11-02 2012-05-23 山东大学 一种槲皮素纳米胶束制剂及其制备方法
CN102793678B (zh) * 2011-05-26 2017-06-30 邓世明 一种不含吐温的多烯紫杉醇注射剂的制备方法
DE102011108948A1 (de) * 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
JP5456802B2 (ja) * 2012-01-23 2014-04-02 株式会社Ｃａｃ 細胞遊走促進剤及び創傷治療用の経皮吸収剤
AU2014291615B2 (en) * 2013-07-17 2019-09-26 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR102086316B1 (ko) * 2019-09-09 2020-03-09 한국콜마주식회사 경피흡수성이 우수한 화장료 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
SA95160463B1 (ar) * 1994-12-22 2005-10-04 استرا أكتيبولاج مساحيق للاستنشاق

Also Published As

Publication number Publication date
TR200001977T2 (tr) 2000-12-21
BR9813811A (pt) 2000-10-03
PL341361A1 (en) 2001-04-09
HUP0102365A3 (en) 2002-01-28
EP1043973A1 (en) 2000-10-18
AU1993599A (en) 1999-07-12
JP2001526210A (ja) 2001-12-18
ID26945A (id) 2001-02-22
IL136880A0 (en) 2001-06-14
ZA9811461B (en) 1999-06-22
CN1283106A (zh) 2001-02-07
AR017220A1 (es) 2001-08-22
KR20010024789A (ko) 2001-03-26
SK9532000A3 (en) 2000-11-07
NZ505073A (en) 2002-09-27
HUP0102365A2 (hu) 2001-11-28
SE9704833D0 (sv) 1997-12-22
EE200000388A (et) 2002-02-15
CA2315782A1 (en) 1999-07-01
NO20003220D0 (no) 2000-06-21
WO1999032089A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
NO20003220D0 (no) Farmasøytiske preparater innbefattende miceller omfattende lipofilt glukokortikosteroid og kun ett overflateaktivt middel
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
DK1015596T3 (da) Fusionsproteiner omfattende HIV-1 Tat- og/eller Nef-proteiner
NO20014219L (no) <Kappa>-agonist-forbindelser og farmasöytiske preparater derav
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
FI954204A7 (fi) Ruiskeena annettavat liposomilääkevalmisteet
IS5409A (is) Útskipt karboxamídóþíasól, framleiðsla þeirra og lyfjablöndur sem innihalda þau
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
ITMI982280A0 (it) Alcune n-(2-april-propionil)-solfonammidi e preparazioni farmaceutiche che le contengono
DE69831486D1 (de) Antiproliferative zubereitungen
NO993868D0 (no) 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike
HUT77235A (hu) Dermálisan alkalmazható parazita elleni készítmények, és ezek előállítása
DK1071407T3 (da) Lipofile mikropartikler indeholdende et proteinlægemiddel eller et antigen og formulering omhandlende samme
EE200200038A (et) Konservitud farmatseutilised preparaadid
NO993315D0 (no) Raskt frigjörende og smaksmaskerende farmasöytisk doseringsform
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
ATE332132T1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
DE69926012D1 (de) Arzneizubereitungen
NO994619L (no) Farmasöytiske blandinger
NO20003141D0 (no) Farmasøytiske blandinger
DE69906934D1 (de) Arzneizubereitungen
EP1142589A4 (en) Medicinal preparations
DK1216021T3 (da) Farmaceutiske og/eller kosmetiske præparater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application